Anti-Annexin A1 antibody
| Name | Anti-Annexin A1 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab33061 |
| Prices | $392.00 |
| Sizes | 100 µl |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ICC/IF WB IHC-P ELISA FC |
| Species Reactivities | Human, Cat, Chimpanzee |
| Antigen | Synthetic peptide: MAMVSEFLKQ AWFIENEEQE YVQTVKSSKG GPGSAVSPYP TFNPSSDVAA, corresponding to a region within N terminal amino acids 1-50 of Human Annexin A1 |
| Description | Rabbit Polyclonal |
| Gene | ANXA1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Ab33061, at 4 µg/ml, staining Annexin A1 in paraffin embedded human intestine tissue sections by Immuonhistochemistry. The arrows indicate the positively labelled cells (epithelial cells of intestinal glands). Magnification: 400X.Ab33061, at 4 µg/ml, staining Annexin A1 in paraffin embedded human intestine tissue sections by Immuonhistochemistry. The arrows indicate the positively labelled cells (epithelial cells of intestinal glands). Magnification: 400X.
All lanes : Anti-Annexin A1 antibody (ab33061) at 2.5 µg/mlLane 1 : HepG2 cell lysateLane 2 : HepG2 cell lysate with blocking peptide at 2 µg/mlLysates/proteins at 25 µg per lane.
Lane 1 : Anti-Annexin A1 antibody (ab33061) at 5 µg/mlLane 2 : Anti-Annexin A1 antibody (ab33061) at 2.5 µg/mlLane 3 : Anti-Annexin A1 antibody (ab33061) at 1.25 µg/mlLane 1 : Cell lysate prepared from human HepG2 cellsLane 2 : Cell lysate prepared from human HepG2 cellsLane 3 : Cell lysate prepared from human HepG2 cellsLysates/proteins at 25 µg per lane.
developed using the ECL techniquePerformed under reducing conditions.
developed using the ECL techniquePerformed under reducing conditions.
developed using the ECL techniquePerformed under reducing conditions.
developed using the ECL techniquePerformed under reducing conditions.
developed using the ECL techniquePerformed under reducing conditions.
Product References
Multi-faceted proteomic characterization of host protein complement of Rift - Multi-faceted proteomic characterization of host protein complement of Rift
Nuss JE, Kehn-Hall K, Benedict A, Costantino J, Ward M, Peyser BD, Retterer CJ, Tressler LE, Wanner LM, McGovern HF, Zaidi A, Anthony SM, Kota KP, Bavari S, Hakami RM. PLoS One. 2014 May 8;9(5):e93483.
Annexin A1 mediates the anti-inflammatory effects during the granulocytic - Annexin A1 mediates the anti-inflammatory effects during the granulocytic
Tsai WH, Chien HY, Shih CH, Lai SL, Li IT, Hsu SC, Kou YR, Hsu HC. J Cell Physiol. 2012 Nov;227(11):3661-9.
Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of - Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of
Tyburczy ME, Kotulska K, Pokarowski P, Mieczkowski J, Kucharska J, Grajkowska W, Roszkowski M, Jozwiak S, Kaminska B. Am J Pathol. 2010 Apr;176(4):1878-90.
Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety. - Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.
Lilly EA, Yano J, Fidel PL Jr. Mol Oral Microbiol. 2010 Aug;25(4):293-304. doi:
Annexin-1 downregulation is associated with clinical outcome in Chinese patients - Annexin-1 downregulation is associated with clinical outcome in Chinese patients
Wang D, Zhang H, Fang Z, Yu G. Eur Surg Res. 2010;45(3-4):151-7.
Genomic profiles of damage and protection in human intracerebral hemorrhage. - Genomic profiles of damage and protection in human intracerebral hemorrhage.
Carmichael ST, Vespa PM, Saver JL, Coppola G, Geschwind DH, Starkman S, Miller CM, Kidwell CS, Liebeskind DS, Martin NA. J Cereb Blood Flow Metab. 2008 Nov;28(11):1860-75.
Use of fluorescence-activated vesicle sorting for isolation of Naked2-associated, - Use of fluorescence-activated vesicle sorting for isolation of Naked2-associated,
Cao Z, Li C, Higginbotham JN, Franklin JL, Tabb DL, Graves-Deal R, Hill S, Cheek K, Jerome WG, Lapierre LA, Goldenring JR, Ham AJ, Coffey RJ. Mol Cell Proteomics. 2008 Sep;7(9):1651-67.